Dissecting the Essential Role of Anomeric β-Triflates in Glycosylation Reactions
Glycosylations promoted by reagent triflate produce synthetic methods for the construction of scaffolding glycosidic spacious and glycoconjugates interests of biology and chemistry.
The process is expected to continue with the participation of a large number of high-energy activated intermediates such as triflates α- and β-glycosylation, or even more unstable glycosyl oxocarbenium-like species, of which only α-glycosyl triflates have been well characterized under reaction conditions representative. Interestingly, the remaining intermediates are less accessible, experimental yet described, seems to be very relevant in the α-selective process, which involves the weak acceptor.
Here, we report a detailed analysis of some paradigmatic examples and illustrations of the reaction, using a combination of chemicals, NMR, kinetic and theoretical approaches, which culminated in the unprecedented detection and quantification really β-glycosyl triflate intermediates in the mix of donor activated. This achievement is further used as a springboard for the characterization of the dynamics of triflate anomerization, which along with the substitution of the acceptor, adjust the stereochemical outcome of the reaction.
The data obtained convincingly show that, even for the reactions were very dissociative involving β-close ion pair (β-CIP) species, the formation of α-glycosides are of course preceded by a bimolecular α → β triflate interconversion, which under certain circumstances be level-step limit. Overall, our results rule out the prevalence of Curtin-Hammett rapid exchange assumption for most glycosylations and highlights the different reactivity properties of α- and β-glycosyl triflates to neutral acceptor and anion.

Click chemistry compared with thiols chemistry for the synthesis of site-selective glycoconjugate vaccine use as a carrier protein CRM 197
Conjugation chemistry is one of the main parameters affecting the immunogenicity of the vaccine glycoconjugate and rational approach towards a deeper understanding of their mechanisms of action will benefit from a very clear structure and well-marked. Here, different conjugation methods were investigated with the aim of controlling the glycosylation site and the density of the carrier protein glycosylation.
S. Typhimurium lipopolysaccharide O-antigen and the carrier protein CRM197 is used as a model. In particular, thiols and click chemistry is checked, both involving the linkage of the terminal reducing sugar units of O-antigen chain of different amino acids in the protein carrier. Thiol chemistry O-antigen conjugate is allowed only when the carrier protein is activated on the lysines and the relatively high number of linker, while the click chemistry allowed conjugate generation even when only one position on the protein activated and sites for both lysine and tyrosine.
Study Highlights click chemistry as a leading approach to the synthesis of glycoconjugates defined, useful to investigate the relationship between design conjugates and immune response. Schistosoma mansoni worms such as the release of excretion / secretory (E / S) products which modulate host immunity to allow infection. extracellular vesicles (EV) between this E / S products, yet the molecular mechanisms and function of S. mansoni EV interaction with the host immune cells is unknown.
Alpha-bungarotoxin, CF405s |
|||
00002-100ug | Biotium | 100uG | EUR 193.2 |
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF680r |
|||
9-00003 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin, CF680r |
|||
9-00003 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF640r |
|||
9-00004 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin, CF640r |
|||
9-00004 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF488a |
|||
9-00005 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin CF488a |
|||
9-00005 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF568 |
|||
9-00006 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin, CF568 |
|||
9-00006 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF594 |
|||
9-00007 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin CF594 |
|||
9-00007 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF633 |
|||
9-00009 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-bungarotoxin, CF633 |
|||
9-00009 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin |
|||
00010-1 | Biotium | 1MG | EUR 201.6 |
Description: Minimum order quantity: 1 unit of 1MG |
Fluorescein-Alpha-bungarotoxin |
|||
00011 | Biotium | 500uG | EUR 440.4 |
Description: Minimum order quantity: 1 unit of 500uG |
Tetramethylrhodamine-Alpha-bungarotoxin |
|||
00012 | Biotium | 500uG | EUR 459.6 |
Description: Minimum order quantity: 1 unit of 500uG |
Fluorescein-alpha-bungarotoxin: (10x50ug) |
|||
00013 | Biotium | 10ST | EUR 500.4 |
Description: Minimum order quantity: 1 unit of 10ST |
Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug) |
|||
00014 | Biotium | 10ST | EUR 559.2 |
Description: Minimum order quantity: 1 unit of 10ST |
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug) |
|||
00015 | Biotium | 500uG | EUR 559.2 |
Description: Minimum order quantity: 1 unit of 500uG |
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug) |
|||
00016 | Biotium | 10ST | EUR 627.6 |
Description: Minimum order quantity: 1 unit of 10ST |
Biotin-xx-a-bungarotoxin |
|||
00017 | Biotium | 500uG | EUR 519.6 |
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-Bungarotoxin, CF555 conjugate |
|||
9-00018 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
Alpha-Bungarotoxin, CF555 conjugate |
|||
9-00018 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100ug |
Biotin-cAMP, diisopropylethylammonium salt: |
|||
00020 | Biotium | 1MG | EUR 376.8 |
Description: Minimum order quantity: 1 unit of 1MG |
Biotin-cAMP, diisopropylethylammonium salt: (20x50ug) |
|||
00020-1 | Biotium | 20ST | EUR 501.6 |
Description: Minimum order quantity: 1 unit of 20ST |
Biotin-cGMP, diisopropylethylammonium salt: |
|||
00021 | Biotium | 1MG | EUR 412.8 |
Description: Minimum order quantity: 1 unit of 1MG |
Biotin-cGMP, diisopropylethylammonium salt: (20x50ug) |
|||
00021-1 | Biotium | 20ST | EUR 537.6 |
Description: Minimum order quantity: 1 unit of 20ST |
Cyanine 644-cAMP: |
|||
00022 | Biotium | 1MG | EUR 589.2 |
Description: Minimum order quantity: 1 unit of 1MG |
Cyanine 644-cAMP: (20x50ug) |
|||
00022-1 | Biotium | 20ST | EUR 750 |
Description: Minimum order quantity: 1 unit of 20ST |
Fluorescein Methotrexate, triammonium salt: |
|||
00023 | Biotium | 1MG | EUR 337.2 |
Description: Minimum order quantity: 1 unit of 1MG |
Staurosporine |
|||
00025 | Biotium | 100uG | EUR 166.8 |
Description: Minimum order quantity: 1 unit of 100uG |
Alpha-bungarotoxin, CF543 |
|||
00026 | Biotium | 500uG | EUR 592.8 |
Description: Minimum order quantity: 1 unit of 500uG |
Rhodamine phalloidin 300u |
|||
00027 | Biotium | 300 | EUR 414 |
Description: Minimum order quantity: 1 unit of 300 |
Biotin-xx-phalloidin |
|||
00028 | Biotium | 100U | EUR 513.6 |
Description: Minimum order quantity: 1 unit of 100U |
Fluorescein-phalloidin |
|||
00030 | Biotium | 300U | EUR 414 |
Description: Minimum order quantity: 1 unit of 300U |
Rhodamine 110 phalloidin |
|||
00032 | Biotium | 300ST | EUR 414 |
Description: Minimum order quantity: 1 unit of 300ST |
Sulforhodamine 101 (Texas-Red) Phalloidin |
|||
00033 | Biotium | 300EU | EUR 414 |
Description: Minimum order quantity: 1 unit of 300EU |
Phalloidin, CF405M |
|||
00034 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF405M |
|||
00034-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
CF488A-cAMP |
|||
00036 | Biotium | 100ug | EUR 206.4 |
Description: Minimum order quantity: 1 unit of 100ug |
CF640R-cAMP |
|||
00037 | Biotium | 100ug | EUR 206.4 |
Description: Minimum order quantity: 1 unit of 100ug |
Phalloidin, CF555 |
|||
00040 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF555 |
|||
00040-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF647 |
|||
00041 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF647 |
|||
00041-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF488A |
|||
00042 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF488A |
|||
00042-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF543 |
|||
00043 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF543 |
|||
00043-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF568 |
|||
00044 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF568 |
|||
00044-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF594 |
|||
00045 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF594 |
|||
00045-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF633 |
|||
00046 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF633 |
|||
00046-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF660R |
|||
00047 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF660R |
|||
00047-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF680R |
|||
00048 | Biotium | 300U | EUR 559.2 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF680R |
|||
00048-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF350 |
|||
00049 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF350 |
|||
00049-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF640R |
|||
00050 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF640R |
|||
00050-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF532 |
|||
00051 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF532 |
|||
00051-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF660C |
|||
00052 | Biotium | 300U | EUR 530.4 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF660C |
|||
00052-T | Biotium | 50U | EUR 159.6 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF680 |
|||
00053 | Biotium | 300U | EUR 559.2 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF680 |
|||
00053-T | Biotium | 50U | EUR 176.4 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF430 |
|||
00054 | Biotium | 300U | EUR 538.8 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF430 |
|||
00054-T | Biotium | 50U | EUR 166.8 |
Description: Minimum order quantity: 1 unit of 50U |
Phalloidin, CF440 |
|||
00055 | Biotium | 300U | EUR 538.8 |
Description: Minimum order quantity: 1 unit of 300U |
Phalloidin, CF440 |
|||
00055-T | Biotium | 50U | EUR 166.8 |
Description: Minimum order quantity: 1 unit of 50U |
Cholera Toxin Subunit B, CF488A conjugate |
|||
00070 | Biotium | 100ug | EUR 313.2 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF568 conjugate |
|||
00071 | Biotium | 100ug | EUR 313.2 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF594 conjugate |
|||
00072 | Biotium | 100ug | EUR 313.2 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF640R conjugate |
|||
00073 | Biotium | 100ug | EUR 316.8 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF532 conjugate |
|||
00074 | Biotium | 100ug | EUR 316.8 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF543 conjugate |
|||
00075 | Biotium | 100ug | EUR 316.8 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF620R conjugate |
|||
00076 | Biotium | 100ug | EUR 316.8 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF633 conjugate |
|||
00077 | Biotium | 100ug | EUR 316.8 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF660R conjugate |
|||
00078 | Biotium | 100ug | EUR 316.8 |
Description: Minimum order quantity: 1 unit of 100ug |
Cholera Toxin Subunit B, CF680R conjugate |
|||
00079 | Biotium | 100ug | EUR 338.4 |
Description: Minimum order quantity: 1 unit of 100ug |
Human Transferrin, CF488A conjugate |
|||
00081 | Biotium | 1mg | EUR 178.8 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF543 conjugate |
|||
00082 | Biotium | 1mg | EUR 178.8 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF568 conjugate |
|||
00083 | Biotium | 1mg | EUR 178.8 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF594 conjugate |
|||
00084 | Biotium | 1mg | EUR 178.8 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF640R conjugate |
|||
00085 | Biotium | 1mg | EUR 178.8 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF680R conjugate |
|||
00086 | Biotium | 1mg | EUR 178.8 |
Description: Minimum order quantity: 1 unit of 1mg |
Human Transferrin, CF750 conjugate |
|||
00087 | Biotium | 1mg | EUR 186 |
Description: Minimum order quantity: 1 unit of 1mg |
HIV-1 tat recombinant antigen |
|||
00110-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV-1 tat recombinant antigen full length 15 kDa |
HIV-1 tat recombinant antigen |
|||
00110-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV-1 tat recombinant antigen full length 15 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 nef recombinant antigen |
|||
00112-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
HIV-1 nef recombinant antigen |
|||
00112-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
HIV-1 env gp41 recombinant antigen |
|||
00113-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
HIV-1 env gp41 recombinant antigen |
|||
00113-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
HIV-2 GP 36 Recombinant Antigen |
|||
00114-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
HIV-2 GP 36 Recombinant Antigen |
|||
00114-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
HCV core recombinant antigen |
|||
00115-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
HCV core recombinant antigen |
|||
00115-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
HCV core recombinant antigen, Biotin conjugate |
|||
00115-V-B-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
HCV core recombinant antigen, Biotin conjugate |
|||
00115-V-B-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
HCV core recombinant antigen, FITC conjugate |
|||
00115-V-F-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
HCV core recombinant antigen, FITC conjugate |
|||
00115-V-F-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
HCV core recombinant antigen, Rhodamine |
|||
00115-V-R-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
HCV core recombinant antigen, Rhodamine |
|||
00115-V-R-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
HCV NS4 recombinant antigen NS4a+b |
|||
00116-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
HCV NS4 recombinant antigen NS4a+b |
|||
00116-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
HCV NS4 recombinant antigen NS4a+b, Biotin |
|||
00116-V-B-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
HCV NS4 recombinant antigen NS4a+b, Biotin |
|||
00116-V-B-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
HCV NS4 recombinant antigen NS4a+b, FITC |
|||
00116-V-F-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
HCV NS4 recombinant antigen NS4a+b, FITC |
|||
00116-V-F-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
HCV NS4 recombinant antigen NS4a+b, Rhodamine |
|||
00116-V-R-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
HCV NS4 recombinant antigen NS4a+b, Rhodamine |
|||
00116-V-R-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
HCV NS3 recombinant antigen |
|||
00117-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
HCV NS3 recombinant antigen |
|||
00117-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
HBV core recombinant antigen |
|||
00120-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
HBV core recombinant antigen |
|||
00120-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
HBV core recombinant antigen, Delta |
|||
00121-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
HBV core recombinant antigen, Delta |
|||
00121-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
HBV surface recombinant antigen HBsAg |
|||
00122-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
HBV surface recombinant antigen HBsAg |
|||
00122-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
HBV surface recombinant antigen HBsAg antigen |
|||
00123-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
HBV surface recombinant antigen HBsAg antigen |
|||
00123-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
HBV surface recombinant antigen HBsAg antigen |
|||
00124-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
HBV surface recombinant antigen HBsAg antigen |
|||
00124-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
HEV (Birma) ORF2 recombinant antigen |
|||
00131-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
HEV (Birma) ORF2 recombinant antigen |
|||
00131-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
HEV (Birma) ORF2 recombinant antigen |
|||
00132-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
HEV (Birma) ORF2 recombinant antigen |
|||
00132-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
AA 403-461 HEV Birma ORF2 Recombinant Antigen |
|||
00133-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
AA 403-461 HEV Birma ORF2 Recombinant Antigen |
|||
00133-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
T, Pallidum recombinant antigen p15 |
|||
00141-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: T. Pallidum recombinant antigen p15 (full length) |
T, Pallidum recombinant antigen p15 |
|||
00141-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: T. Pallidum recombinant antigen p15 (full length) |
T, Pallidum recombinant antigen p17 |
|||
00142-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: T. Pallidum recombinant antigen p17 (full length) |
T, Pallidum recombinant antigen p17 |
|||
00142-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: T. Pallidum recombinant antigen p17 (full length) |
T, Pallidum recombinant antigen p45 |
|||
00143-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: T. Pallidum recombinant antigen p45 (full length) |
T, Pallidum recombinant antigen p45 |
|||
00143-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: T. Pallidum recombinant antigen p45 (full length) |
T, pallidum recombinant antigen TmpA |
|||
00144-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: T. Pallidum recombinant antigen TmpA (full length) |
T, pallidum recombinant antigen TmpA |
|||
00144-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: T. Pallidum recombinant antigen TmpA (full length) |
HCV core 2-119aa recombinant antigen |
|||
00150-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
HCV core 2-119aa recombinant antigen |
|||
00150-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
HCV Core 24 Antigen |
|||
00151-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV core 24 antigen. |
HCV Core 24 Antigen |
|||
00151-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV core 24 antigen. |
HCV core recombinant antigen |
|||
00152-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV core recombinant antigen a.a.105-302 |
HCV core recombinant antigen |
|||
00152-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV core recombinant antigen a.a.105-302 |
HCV NS3 1192-1456 aa Recombinant Antigen |
|||
00153-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a |
HCV NS3 1192-1456 aa Recombinant Antigen |
|||
00153-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a |
HCV NS3 1359-1456aa antigen |
|||
00154-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 |
HCV NS3 1359-1456aa antigen |
|||
00154-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 |
HCV NS4 mosaic recombinant antigen |
|||
00155-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. |
HCV NS4 mosaic recombinant antigen |
|||
00155-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. |
HCV NS4 1916-1947aa recombinant antigen |
|||
00156-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS4 1916-1947aa recombinant antigen. |
HCV NS4 1916-1947aa recombinant antigen |
|||
00156-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS4 1916-1947aa recombinant antigen. |
HCV NS5 2061-2302aa recombinant antigen |
|||
00157-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS5 2061-2302aa recombinant antigen. |
HCV NS5 2061-2302aa recombinant antigen |
|||
00157-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS5 2061-2302aa recombinant antigen. |
HCV NS5 2212-2313aa recombinant antigen |
|||
00158-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. |
HCV NS5 2212-2313aa recombinant antigen |
|||
00158-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. |
HAV VP1-P2A recombinant antigen |
|||
00159-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HAV VP1-P2A recombinant antigen a.a. 722-830. |
HAV VP1-P2A recombinant antigen |
|||
00159-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HAV VP1-P2A recombinant antigen a.a. 722-830. |
HAV VP4-VP2 recombinant antigen |
|||
00160-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HAV VP4-VP2 recombinant antigen a.a. 55-164. |
HAV VP4-VP2 recombinant antigen |
|||
00160-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HAV VP4-VP2 recombinant antigen a.a. 55-164. |
HAV P2C-P3A recombinant antigen |
|||
00161-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HAV P2C-P3A recombinant antigen a.a. 1492-1606. |
HAV P2C-P3A recombinant antigen |
|||
00161-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HAV P2C-P3A recombinant antigen a.a. 1492-1606. |
HAV P3C recombinant antigen |
|||
00162-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HAV P3C recombinant antigen a.a. 1643-1743. |
HAV P3C recombinant antigen |
|||
00162-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HAV P3C recombinant antigen a.a. 1643-1743. |
HAV VP3 recombinant antigen |
|||
00163-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HAV VP3 recombinant antigen a.a. 304-415. |
HAV VP3 recombinant antigen |
|||
00163-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HAV VP3 recombinant antigen a.a. 304-415. |
HAV VP1-P2A recombinant antigen |
|||
00164-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HAV VP1-P2A recombinant antigen a.a. 669-782. |
HAV VP1-P2A recombinant antigen |
|||
00164-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HAV VP1-P2A recombinant antigen a.a. 669-782. |
HAV HAV P2C recombinant antigen |
|||
00165-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HAV HAV P2C recombinant antigen a.a. 1121-1234. |
HAV HAV P2C recombinant antigen |
|||
00165-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HAV HAV P2C recombinant antigen a.a. 1121-1234. |
HAV P2C-P3A recombinant antigen |
|||
00166-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HAV P2C-P3A recombinant antigen a.a. 1392-1521. |
HAV P2C-P3A recombinant antigen |
|||
00166-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HAV P2C-P3A recombinant antigen a.a. 1392-1521. |
Here we show that EVs are released by S. mansoni schistosomula internalized by monocyte-derived human dendritic cells (moDCs). Importantly, we show that the uptake is mainly mediated by DC-SIGN (CD209). Blocking DC-SIGN is almost completely canceled EV uptake, while blocking the mannose receptor (MR, CD206) or dendritic cell immunoreceptor (DCIR, CLEC4A) had no effect on EV uptake.